HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Gestational trophoblastic disease — Clinical Guidelines

Overview

Gestational trophoblastic disease (GTD) encompasses a spectrum of pregnancy-related conditions ranging from benign molar pregnancies to malignant trophoblastic tumors, generally with favorable outcomes when treated appropriately 1.

Diagnosis

Histopathological Analysis: Routine histopathological examination of pregnancy tissue is essential for diagnosis 3.

Ultrasound: Utilized for initial screening and monitoring 3.

Serum Beta-hCG Levels: Monitoring levels crucial for follow-up and treatment response 1.

DNA Genotyping: STR genotyping aids in resolving tissue mislabeling and contamination issues 2.

Management

First-Line Treatment: Methotrexate is commonly used for low-risk GTN 1.

Chemotherapy: EMA/CO regimen (Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide, Vincristine) for high-risk GTN 1.

Follow-Up: Regular monitoring of beta-hCG levels post-treatment to ensure remission 1.

Referral for Chemotherapy: Centers lacking chemotherapy facilities refer patients elsewhere 4.

Special Populations

Pregnancy: Management strategies may vary based on gestational status and risk stratification 1.

Comorbidities: Specific considerations for comorbidities are not extensively detailed in provided abstracts 3.

Key Recommendations

Routine histopathological analysis of pregnancy tissue is essential for diagnosing GTD (Evidence: Strong 3).

Centralized coordination of care through specialized centers improves outcomes in developing countries (Evidence: Moderate 4).

Regular monitoring of serum beta-hCG levels is critical for follow-up and assessing treatment efficacy (Evidence: Strong 1).

STR genotyping should be considered for resolving diagnostic ambiguities and ensuring accurate tissue identity (Evidence: Moderate 2).

High-risk GTN requires aggressive chemotherapy regimens like EMA/CO (Evidence: Strong 1).

References

1 Lok C, van Trommel N, Braicu EI, Planchamp F, Berkowitz R, Seckl M. Practical Guidelines for the Treatment of Gestational Trophoblastic Disease: Collaboration of the European Organisation for the Treatment of Trophoblastic Disease (EOTTD)-European Society of Gynaecologic Oncology (ESGO)-Gynecologic Cancer InterGroup (GCIG)-International Society for the Study of Trophoblastic Diseases (ISSTD). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2025. link 2 Baine I, Hui P. Practical applications of DNA genotyping in diagnostic pathology. Expert review of molecular diagnostics 2019. link 3 Kladnitski M, Kenwright D. Management of gestational trophoblastic disease: a survey of New Zealand O&G practice. The New Zealand medical journal 2016. link 4 Braga A, Burlá M, Freitas F, Uberti E, Viggiano M, Sun SY et al.. Centralized Coordination of Decentralized Assistance for Patients with Gestational Trophoblastic Disease in Brazil: A Viable Strategy for Developing Countries. The Journal of reproductive medicine 2016. link 5 Montoneri C, Garozzo G, Granà G. The incidence and follow-up of the trophoblastic disease in ten-years period 1971-80. European journal of gynaecological oncology 1983. link 6 Wetzel WJ. Trophoblastic pseudotumor: An illustrative case. Diagnostic gynecology and obstetrics 1980. link

Gestational trophoblastic disease